| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |